Latest Asx Price Query News

Northern Minerals Limited has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting ongoing project developments and market factors influencing its share price.

Blackstone Minerals has clarified that its recent share price jump is driven by market anticipation of its merger with IDM International, with no undisclosed information influencing trading.

Redox Limited has dismissed any undisclosed information behind its recent share price plunge, attributing the volatility to analyst downgrades and broader economic concerns.

Battery Age Minerals Ltd (ASX, BM8) has responded to an ASX price query following a notable jump in its share price and trading volume, attributing the activity to recent public communications and exploration progress.

Black Canyon Limited has clarified that its recent share price and volume spike is linked to the upcoming second phase of drilling at its Wandanya manganese project, with no undisclosed information influencing trading.

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

West Wits Mining Limited (WWI) has addressed recent spikes in its share price and trading volume, linking the activity to funding developments, a strong gold price, and positive market commentary.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

The ASX has formally queried Bougainville Copper Limited following an unexpected surge in its share price and trading volume, seeking clarity on any undisclosed information that might explain the market activity.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.